Background: The role of peritoneal wash cytology (PWC) in endometrial cancer has fluctuated over five decades. It was introduced into FIGO endometrial cancer staging in 1988 as Stage IIIA but was removed in 2009 when evidence showed that cytology alone lacked independent prognostic value. In the molecular era, its relevance is being reconsidered. Methods: A systematic search of PubMed/MEDLINE, Embase, Web of Science, and Cochrane Library (inception—30 August 2025) identified studies assessing PWC in endometrial cancer. Eligible designs included cohort, case-control, randomized trials, meta-analyses, guidelines reporting recurrence and survival outcomes, and treatment recommendations. Results: Eighteen studies were included. Classic cohorts demonstrated no survival disadvantage with cytology-only positivity, supporting its removal from FIGO staging. However, national databases and meta-analyses suggested adverse prognostic associations, particularly in high-risk disease. Recent molecular-era studies highlight that PWC’s prognostic impact is subtype-specific: adverse in p53-abnormal and No Specific Molecular Profile (NSMP) tumors, but not in POLE-mutated or Mismatch Repair deficient ( MMRd) cancers . Current National Comprehensive Cancer Network (NCCN) guidelines still incorporate PWC in treatment decisions for high-risk histology such as serous and clear cell carcinoma. Concerns remain regarding the iatrogenic consequences of surgical factors (e.g., hysteroscopy, distension media) influencing cytology results. Conclusion: PWC no longer defines stage but retains prognostic and therapeutic relevance in high-risk early-stage uterine cancers . Its value may be best realized when integrated with molecular classification. Future prospective, molecular-stratified studies are essential to determine its role in precision oncology.
KeywordsEndometrial CancerCytologyPeritoneal Wash
FIGO Committee on Gynecologic Oncology (1971) Staging Announcements: Carcinoma of the Corpus Uteri. International Journal of Gynecology & Obstetrics , 9, 199-200.
Kashimura, M., Sugihara, K., Toki, N., Matsuura, Y., Kawagoe, T., Kamura, T., et al . (1997) The Significance of Peritoneal Cytology in Uterine Cervix and Endometrial Cancer. Gynecologic Oncology , 67, 285-290. https://doi.org/10.1006/gyno.1997.4858
FIGO Committee on Gynecologic Oncology (1988) Staging of Endometrial Carcinoma. International Journal of Gynecology & Obstetrics , 26, 145-150.
Tebeu, P.M., Popowski, G.Y., Verkooijen, H.M., Casals, J., Lüdicke, F., Zeciri, G., et al . (2003) Impact of Peritoneal Cytology on Survival of Endometrial Cancer Patients Treated with Surgery and Radiotherapy. British Journal of Cancer , 89, 2023-2026. https://doi.org/10.1038/sj.bjc.6601446
Kasamatsu, T., Onda, T., Katsumata, N., Sawada, M., Yamada, T., Tsunematsu, R., et al . (2003) Prognostic Significance of Positive Peritoneal Cytology in Endometrial Carcinoma Confined to the Uterus. British Journal of Cancer , 88, 245-250. https://doi.org/10.1038/sj.bjc.6600698
Wethington, S.L., Barrena Medel, N.I., Wright, J.D. and Herzog, T.J. (2009) Prognostic Significance and Treatment Implications of Positive Peritoneal Cytology in Endometrial Adenocarcinoma: Unraveling a Mystery. Gynecologic Oncology , 115, 18-25. https://doi.org/10.1016/j.ygyno.2009.06.019
Pecorelli, S. (2009) Revised FIGO Staging for Carcinoma of the Vulva, Cervix, and Endometrium. International Journal of Gynecology & Obstetrics , 105, 103-104. https://doi.org/10.1016/j.ijgo.2009.02.012
National Comprehensive Cancer Network (NCCN) (2025) Uterine Neoplasms, Version 1.2025. NCCN Clinical Practice Guidelines in Oncology.
Sterne, J.A.C., Savović, J., Page, M.J., Elbers, R.G., Blencowe, N.S., Boutron, I., et al . (2019) Rob 2: A Revised Tool for Assessing Risk of Bias in Randomised Trials. BMJ , 366, Article l4898. https://doi.org/10.1136/bmj.l4898
Page, M.J., McKenzie, P.M., Bossuyt, I., Boutron, T.C., Hoffmann, T.C., Mulrow, C.D., et al . (2021) The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews. BMJ , 372, n71.
Yazigi, R., Piver, S.M. and Blumenson, L. (1983) Malignant Peritoneal Cytology as Prognostic Indicator in Stage I Endometrial Cancer. Obstetrics & Gynecology , 62, 359-362. https://doi.org/10.1097/00006250-198309000-00019
Mazurka, J.L., Krepart, G.V. and Lotocki, R.J. (1988) Prognostic Significance of Positive Peritoneal Cytology in Endometrial Carcinoma. American Journal of Obstetrics and Gynecology , 158, 303-306. https://doi.org/10.1016/0002-9378(88)90143-3
Grimshaw, R.N., Carl Tupper, W., Fraser, R.C., Tompkins, M.G. and Jeffrey, J.F. (1990) Prognostic Value of Peritoneal Cytology in Endometrial Carcinoma. Gynecologic Oncology , 36, 97-100. https://doi.org/10.1016/0090-8258(90)90116-3
Descamps, P., Calais, G., Moire, C., Bertrand, P., Castiel, M., Le Floch, O., et al . (1997) Predictors of Distant Recurrence in Clinical Stage I or II Endometrial Carcinoma Treated by Combination Surgical and Radiation Therapy. Gynecologic Oncology , 64, 54-58. https://doi.org/10.1006/gyno.1996.4511
Obermair, A., Geramou, M., Gucer, F., et al . (2001) Peritoneal Cytology: Impact on Disease-Free Survival in Surgically Staged Endometrial Cancer. European Journal of Surgical Oncology , 27, 629-633.
Takeshima, N., Nishida, H., Tabata, T., Hirai, Y. and Hasumi, K. (2001) Positive Peritoneal Cytology in Endometrial Cancer: Enhancement of Other Prognostic Indicators. Gynecologic Oncology , 82, 470-473. https://doi.org/10.1006/gyno.2001.6301
Preyer, O., Obermair, A., Formann, E., Schmid, W., Perrin, L.C., Ward, B.G., et al . (2002) The Impact of Positive Peritoneal Washings and Serosal and Adnexal Involvement on Survival in Patients with Stage IIIA Uterine Cancer. Gynecologic Oncology , 86, 269-273. https://doi.org/10.1006/gyno.2002.6744
Tebeu, P., Popowski, Y., Verkooijen, H.M., Bouchardy, C., Ludicke, F., Usel, M., et al . (2004) Positive Peritoneal Cytology in Early-Stage Endometrial Cancer Does Not Influence Prognosis. British Journal of Cancer , 91, 720-724. https://doi.org/10.1038/sj.bjc.6602035
Saga, Y., Imai, M., Jobo, T., Kuramoto, H., Takahashi, K., Konno, R., et al . (2006) Is Peritoneal Cytology a Prognostic Factor of Endometrial Cancer Confined to the Uterus? Gynecologic Oncology , 103, 277-280. https://doi.org/10.1016/j.ygyno.2006.03.003
Gultekin, M., Yildiz, F., Ozyigit, G., Beyaz, H., Hayran, M., Kose, F., et al . (2012) Comparison of FIGO 1988 and 2009 Staging Systems for Endometrial Carcinoma. Medical Oncology , 29, 2955-2962. https://doi.org/10.1007/s12032-012-0196-x
Garg, G., Gao, F., Wright, J.D., Hagemann, A.R., Mutch, D.G. and Powell, M.A. (2013) Positive Peritoneal Cytology Is an Independent Risk-Factor in Early Stage Endometrial Cancer. Gynecologic Oncology , 128, 77-82. https://doi.org/10.1016/j.ygyno.2012.09.026
Shiozaki, T., Tabata, T., Yamada, T., Yamamoto, Y., Yamawaki, T. and Ikeda, T. (2014) Does Positive Peritoneal Cytology Not Affect the Prognosis for Stage I Uterine Endometrial Cancer? The Remaining Controversy and Review of the Literature. Int ernational Journal of Gynecological Cancer , 24, 549-555. https://doi.org/10.1097/igc.0000000000000072
Seagle, B.L., Alexander, A.L., Lantsman, T. and Shahabi, S. (2018) Prognosis and Treatment of Positive Peritoneal Cytology in Early Endometrial Cancer: Matched Cohort Analyses from the National Cancer Database. American Journal of Obstetrics and Gynecology , 218, 329.e1-329.e15. https://doi.org/10.1016/j.ajog.2017.11.601
Villiger, A., Zurbriggen, S., Imboden, S., Solass, W., Christe, L., Saner, F.A.M., et al . (2024) Reviving Peritoneal Cytology: Exploring Its Role in Endometrial Cancer Molecular Classification. Gynecologic Oncology , 182, 148-155. https://doi.org/10.1016/j.ygyno.2024.01.006
Sakai, K., Yamagami, W., Takahashi, F., Tokunaga, H., Yamamoto, E., Yokoyama, Y., et al . (2025) Prognostic Impact of Peritoneal Cytology on Treating Endometrial Cancer Using Data from the Japan Society of Obstetrics and Gynecology Cancer Registry. Journal of Gynecologic Oncology , 36, e41. https://doi.org/10.3802/jgo.2025.36.e41
Wang, L., Li, L., Wu, M. and Lang, J. (2020) The Prognostic Role of Peritoneal Cytology in Stage IA Endometrial Endometrioid Carcinomas. Current Problems in Cancer , 44, Article 100514. https://doi.org/10.1016/j.currproblcancer.2019.100514
Pergialiotis, V., Panagiotopoulos, M., Koutras, A., Daras, A., Ntounis, T., Liontos, M., et al . (2024) The Impact of Positive Peritoneal Cytology on the Survival Rates of Early-Stage-Disease Endometrial Cancer Patients: Systematic Review and Meta-Analysis. Medicina , 60, Article 733. https://doi.org/10.3390/medicina60050733
Fumagalli, D., De Vitis, L.A., Capasso, I., Fought, A.J., Gree, M.E., Langstraat, C.L., et al . (2023) #892 Positive Peritoneal Cytology in Endometrial Cancer: Is It Significant in Low-Risk Disease? International Journal of Gynecological Cancer , 33, A187.3-A188.
Chang, Y., Zhang, Y., Wang, Y., Wang, L. and Duan, H. (2011) Effect of Hysteroscopy on the Peritoneal Dissemination of Endometrial Cancer Cells: A Meta-Analysis. Fertility and Sterility , 96, 957-961.e2. https://doi.org/10.1016/j.fertnstert.2011.07.1146
Polyzos, N.P., Mauri, D., Tsioras, S., Messini, C.I., Valachis, A. and Messinis, I.E. (2010) Intraperitoneal Dissemination of Endometrial Cancer Cells after Hysteroscopy: A Systematic Review and Meta-Analysis. International Journal of Gynecological Cancer , 20, 261-267. https://doi.org/10.1111/igc.0b013e3181ca2290
Stachowicz, N., Mazurek, D., Kozinski, T. and Czekierdowski, A. (2017) Diagnostic Hysteroscopy and the Risk of Malignant Cells Intraabdominal Spread in Women with Endometrial Cancer. Ginekologia Polska , 88, 562-567. https://doi.org/10.5603/GP.a2017.0101